12:00 AM
Apr 29, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Status

ASLAN003: Phase I start

Next month, Aslan will begin a double-blind, placebo-controlled, Singaporean Phase I trial to evaluate multiple ascending-doses of ASLAN003 in healthy volunteers. Last May, Almirall granted Aslan exclusive,...

Read the full 112 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >